Literature DB >> 12202398

A CD18-dependent protein kinase C beta-mediated alternative cell death pathway of activated monocytes.

Jean-Gabriel Castaigne1, Wenyan Guo, Claire Lévéille, Dominique Charron, Reem Al-Daccak.   

Abstract

Activated monocytes become resistant to numerous death stimuli including death receptors. Given that the uncontrolled activation of monocytes/macrophages and their persistence can lead to severe inflammatory conditions, it is critical to define the pathways that control their elimination. We previously reported that ligation of HLA-DR molecules on peripheral blood-derived monocytes induces their death. To investigate the mechanisms of HLA-DR-mediated death in monocytes, we used the THP-1 monocytic cell line as a model. We show that while THP-1 are equally resistant to HLA-DR- and to Fas-mediated death, treatment of THP-1 with IFN-gamma renders them sensitive to HLA-DR- but not to Fas-mediated death. Both activation of the Src family protein tyrosine kinase and classical protein kinase C (PKC) occur through HLA-DR, but only PKC activation is involved in HLA-DR-mediated death of these cells. Moreover, HLA-DR-mediated cell death of activated monocytes implicates a regulatory loop between the HLA-DR/CD18 complex and the downstream activation of PKCbeta. Thus, our study identifies an alternative physiological signaling pathway of monocyte death, and further investigation on its regulation is likely to provide significant insights into the control of monocyte homeostasis and inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202398     DOI: 10.1093/intimm/dxf071

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  1 in total

1.  Positive Feedback Cycle of TNFα Promotes Staphylococcal Enterotoxin B-Induced THP-1 Cell Apoptosis.

Authors:  Xiaopeng Zhang; Weilong Shang; Jizhen Yuan; Zhen Hu; Huagang Peng; Junmin Zhu; Qiwen Hu; Yi Yang; Hui Liu; Bei Jiang; Yinan Wang; Shu Li; Xiaomei Hu; Xiancai Rao
Journal:  Front Cell Infect Microbiol       Date:  2016-09-21       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.